- Home
- TWIN vs BIOA Comparison
TWIN vs BIOA Comparison
Compare TWIN & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- BIOA
- Stock Information
- Founded
- TWIN 1918
- BIOA 2015
- Country
- TWIN United States
- BIOA United States
- Employees
- TWIN N/A
- BIOA N/A
- Industry
- TWIN Industrial Machinery/Components
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- TWIN Industrials
- BIOA Health Care
- Exchange
- TWIN Nasdaq
- BIOA Nasdaq
- Market Cap
- TWIN 123.7M
- BIOA 144.1M
- IPO Year
- TWIN N/A
- BIOA 2024
- Fundamental
- Price
- TWIN $7.06
- BIOA $4.04
- Analyst Decision
- TWIN Strong Buy
- BIOA Hold
- Analyst Count
- TWIN 1
- BIOA 4
- Target Price
- TWIN $12.00
- BIOA $5.67
- AVG Volume (30 Days)
- TWIN 55.2K
- BIOA 232.7K
- Earning Date
- TWIN 05-07-2025
- BIOA 05-06-2025
- Dividend Yield
- TWIN 2.24%
- BIOA N/A
- EPS Growth
- TWIN N/A
- BIOA N/A
- EPS
- TWIN 0.29
- BIOA N/A
- Revenue
- TWIN $328,478,000.00
- BIOA $1,451,000.00
- Revenue This Year
- TWIN N/A
- BIOA N/A
- Revenue Next Year
- TWIN N/A
- BIOA N/A
- P/E Ratio
- TWIN $24.55
- BIOA N/A
- Revenue Growth
- TWIN 11.49
- BIOA N/A
- 52 Week Low
- TWIN $6.16
- BIOA $2.88
- 52 Week High
- TWIN $15.86
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- TWIN 48.46
- BIOA N/A
- Support Level
- TWIN $6.69
- BIOA N/A
- Resistance Level
- TWIN $7.53
- BIOA N/A
- Average True Range (ATR)
- TWIN 0.44
- BIOA 0.00
- MACD
- TWIN 0.10
- BIOA 0.00
- Stochastic Oscillator
- TWIN 65.69
- BIOA 0.00
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.